BR9812120A - Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação - Google Patents

Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação

Info

Publication number
BR9812120A
BR9812120A BR9812120-0A BR9812120A BR9812120A BR 9812120 A BR9812120 A BR 9812120A BR 9812120 A BR9812120 A BR 9812120A BR 9812120 A BR9812120 A BR 9812120A
Authority
BR
Brazil
Prior art keywords
benzodiazepine
derivatives
dioxolo
pharmaceutical composition
preparation
Prior art date
Application number
BR9812120-0A
Other languages
English (en)
Inventor
Zoltan Ratkai
Jozsef Barkoczy
Geza Schneider
Judit Cselenyak
Gyula Simig
Laszlo Balazs
Imre Doman
Zoltan Greff
Nagy Peter Kotay
Peter Seres
Geza Szabo
Istvan Gacsalyi
Gabor Gigler
Istvan Gyertyan
Gyoergy Levay
Attila Kovacs
Annamaria Simo
Tamas Szabados
Andras Egyed
Miklos Vegh
Karoly Tihanyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9701381A external-priority patent/HUP9701381A3/hu
Priority claimed from HU9701380A external-priority patent/HUP9701380A3/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of BR9812120A publication Critical patent/BR9812120A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"DERIVADOS DE9H-1,3-DIOXOLO/4,5-H//2,3/BENZODIAZEPINA 8,COMPOSIçãO FARMACêUTICA E PROCESSO PAPA SUAPREPAPAçãO". A invenção refere-se a derivados de9H-1,3-dioxolo/4,5-h//2,3/benzodiazepina 8-substituídos, novosda fórmula (I), um processo para preparar estes compostos e acomposições farmacêuticas contendo estas substâncias ativas. Oscompostos (I) inibem receptores Ampa/Kainate.
BR9812120-0A 1997-08-12 1998-08-07 Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação BR9812120A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9701381A HUP9701381A3 (en) 1997-08-12 1997-08-12 New 7,8-dihydro-8,8-disubstituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them
HU9701380A HUP9701380A3 (en) 1997-08-12 1997-08-12 New 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them
PCT/HU1998/000075 WO1999007707A1 (en) 1997-08-12 1998-08-07 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h//2,3/BENZODIAZEPINE DERIVATIVES, AS AMPA/KAINATE RECEPTOR INHIBITORS

Publications (1)

Publication Number Publication Date
BR9812120A true BR9812120A (pt) 2001-11-20

Family

ID=89995497

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812120-0A BR9812120A (pt) 1997-08-12 1998-08-07 Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação

Country Status (18)

Country Link
US (1) US6562810B1 (pt)
EP (1) EP1003749B1 (pt)
JP (1) JP2001512730A (pt)
KR (1) KR20010022862A (pt)
CN (1) CN1109033C (pt)
AT (1) ATE252586T1 (pt)
AU (1) AU735490B2 (pt)
BR (1) BR9812120A (pt)
CA (1) CA2300302A1 (pt)
DE (1) DE69819166T2 (pt)
DK (1) DK1003749T3 (pt)
NO (1) NO20000655L (pt)
NZ (1) NZ503300A (pt)
PL (1) PL338680A1 (pt)
RU (1) RU2208013C2 (pt)
SK (1) SK1772000A3 (pt)
UA (1) UA67749C2 (pt)
WO (1) WO1999007707A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900354A3 (en) * 1999-02-15 2001-02-28 Egyt Gyogyszervegyeszeti Gyar Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
CN100558834C (zh) * 2006-07-21 2009-11-11 华南理工大学 一种环保型干粉涂料及其制备方法
FR2972454B1 (fr) * 2011-03-08 2013-03-01 Servier Lab Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU230684B1 (en) * 2014-01-21 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
CN104391999B (zh) * 2014-12-15 2018-02-02 北京国双科技有限公司 信息推荐方法和装置
SG11201800071PA (en) * 2015-07-06 2018-02-27 Public Univ Corp Yokohama City Univ Novel compound that specifically binds to ampa receptor
RU2634594C1 (ru) * 2016-11-30 2017-11-01 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Ингибиторы образования конечных продуктов гликирования на основе азопроизводных фенилсульфокислот
WO2023042887A1 (ja) 2021-09-15 2023-03-23 国立大学法人 琉球大学 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物
EP4403185A1 (en) 2021-09-15 2024-07-24 University of The Ryukyus Pharmaceutical composition for treating cognitive decline or for treating overweightness or obesity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191702B (en) 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására
DE4428835A1 (de) 1994-08-01 1996-02-08 Schering Ag Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
TR199501070A2 (tr) 1994-08-31 1996-06-21 Lilly Co Eli Dihidro-2,3-benzodiazepin türevinin kristalli bicimi.
TR199501071A2 (tr) 1994-08-31 1996-06-21 Lilly Co Eli Dihidro-2,3-benzodiazepin türevlerinin üretilmesi icin stereoselektif islem.
DE19604919A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP1003749A1 (en) 2000-05-31
ATE252586T1 (de) 2003-11-15
US6562810B1 (en) 2003-05-13
RU2208013C2 (ru) 2003-07-10
WO1999007707A1 (en) 1999-02-18
DE69819166T2 (de) 2004-07-22
NO20000655L (no) 2000-04-10
UA67749C2 (uk) 2004-07-15
KR20010022862A (ko) 2001-03-26
DK1003749T3 (da) 2004-03-08
EP1003749B1 (en) 2003-10-22
PL338680A1 (en) 2000-11-20
CN1109033C (zh) 2003-05-21
CN1272846A (zh) 2000-11-08
AU735490B2 (en) 2001-07-12
DE69819166D1 (de) 2003-11-27
SK1772000A3 (en) 2000-10-09
AU8818198A (en) 1999-03-01
CA2300302A1 (en) 1999-02-18
JP2001512730A (ja) 2001-08-28
NO20000655D0 (no) 2000-02-09
NZ503300A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
BR9811022A (pt) Composto, composição farmacêutica, e, processo para preparação de um composto
BR9810802A (pt) Composto, composição farmacêutica, e, processos para a preparação de um composto, e para tratamento de uma doença de agregação de plaquetas
BR9808540A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica e processo para preparação dos mesmos, uso de um composto, e, processo para produzir a imunossupressão
YU56995A (sh) Soli derivata indola
BR9811028A (pt) Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto
FI954898A (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
BR9812120A (pt) Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação
BR9907934A (pt) Composto, composição farmacêutica, e, processo para a preparação do composto
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
HUP9800512A2 (hu) Moenomicin csoportba tartozó antibiotikumok bizmutsói, eljárás előállításukra, ezek alkalmazása és ezeket tartalmazó gyógyszerkészítmények
IL113365A0 (en) 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
PT99864A (pt) Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
BR9812119A (pt) Derivados de 1,3-dioxolo/4, 5-h//2,3/benzodiazepina, processo para a preparação dos mesmos e composição farmacêutica
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
WO1999005103A3 (en) 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
WO1999058527A3 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
BR9913601A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para a preparação de compostos
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
PT785794E (pt) Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck
EP0980366A4 (en) ANTITHROMOSIS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007.